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Abstract 
Resources for the Future (RFF), in conjunction with the U.S. Environmental Protection Agency, the 
Society for Risk Analysis, and the Electric Power Research Institute, held a workshop Sept. 18–20, 
2000, at the RFF Conference Center in Washington, DC. The intent was to discuss how Bayesian 
approaches could be useful in improving techniques for estimating exposure–response functions. Ten 
distinguished scholars from a range of fields (medical biostatistics, decision sciences, environmental 
engineering, and toxicology) served as faculty. Approximately 80 people attended the workshop. 
Bayesian methods have been applied to a variety of problems in biomedical research and 
environmental risk analysis, including design of clinical trials, estimation of exposures to humans and 
local environments, and, in a few cases, estimation of exposure–response functions. Bayesian 
methods offer two signal advantages: their use requires careful analysis of problem logic, which has 
intrinsic utility, and disparate data can be incorporated into calculations. Although application of 
formal Bayesian analysis can be computationally challenging, widely available computer programs 
now greatly reduce this burden. Participants identified several factors that may impede the 
dissemination of Bayesian approaches among practitioners of dose–response assessment and made 
some recommendations for overcoming these hurdles. 
•  EPA, other regulatory agencies that use dose–response assessment as part of their 
processes, and the private sector all should take steps to foster the use of Bayesian 
approaches.  
•  EPA and other agencies should work to persuade professional societies (for example, 
Society for Risk Analysis, Society of Toxicology) to seek out and recognize meritorious 
analyses that use Bayesian approaches.  
•  EPA and private-sector organizations should consider sponsoring research into using 
Bayesian approaches, demonstration analyses that use them, and using the results of this 
work to help educate peers in the risk analysis and toxicology professions. 
•  EPA should request all staff and contractor scientists who develop mathematical models 
to use Bayesian techniques to calibrate models.  
•  EPA should consider ways to inform its staff, contractors, and the research community as 
to the utility of Bayesian analyses. 
•  EPA should consider improving its research planning by making use of Bayesian 
techniques (including value-of-information analyses).  
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Advanced Methods for Dose–Response Assessment: Bayesian 
Approaches—Final Report 
James Wilson 
Bayesian analysis is an important tool now widely used in many domains, including some parts of 
risk analysis. It provides the foundation for the technical field of decision analysis.1 Although the 
method originated in the eighteenth century, the present widespread application has followed the 
development of modern computing capabilities; formal application requires complex probability 
computations. The fundamental concept of Bayesian logic is that we improve our knowledge by using 
new information to modify what we knew before. (Occasionally, new information overturns previous 
conclusions; but usually, the result is reduced uncertainty.) Some philosophers suggest that Bayesian 
logic—the approach, not necessarily involving actual calculation of probabilities—best describes the 
scientific method.2 
The U.S. Environmental Protection Agency (EPA) asked Resources for the Future (RFF) to organize 
a workshop on the potential for Bayesian approaches to contribute to progress in dose–response 
assessment. The Electric Power Research Institute joined in sponsoring this workshop, which was 
organized jointly by RFF, EPA, and the Society for Risk Analysis. It was held in RFF’s conference 
facilities Sept. 18–20, 2000. This report describes the proceedings of the workshop and records some 
suggestions that may facilitate the adoption of more formal Bayesian approaches within the 
subdiscipline of human health risk assessment.  
Description of the Program 
The workshop agenda appears as Appendix I. Appendix II lists the workshop faculty and panelists, 
and Appendix III gives the attendees. Some useful websites are provided in Appendix IV, and 
Appendix V is a list of some books and papers that describe relevant uses of Bayesian analysis. 
Early on, the workshop’s advisory committee3 raised the issue of just where this workshop would fall 
within the spectrum of Bayesian approaches. At one end, there stand the intuitive (and usually 
unstructured) approaches that most scientists absorb during their apprenticeships in science—these 
approaches are not usually accompanied by an understanding of the underpinning formal logic. At the 
other end stand the formalized decisionmaking procedures that incorporate decision criteria framed in 
                                                       
1 D. Warner North. A tutorial introduction to decision theory. IEEE Transactions on Systems Science and 
Cybernetics 4(3): 200–210 (1968). 
2 C. Howson and P. Urbach. Scientific Reasoning: The Bayesian Approach. La Salle, IL: Open Court Publishing 
Co. (1989). 
3 The advisory committee included Alison Cullen, Victor Hasselblad, Annie Jarabek, Tom Louis, and Warner 
North (affiliations are given in Appendix II.)  Resources for the Future    Wilson 
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utilitarian terms. In between, there is the use of Bayesian logic to structure analysis of problems and 
Bayesian statistics to draw quantitative inferences from numerically encoded information. This 
workshop focused on the two latter topics. Health risk assessment practices are already firmly based 
in science, so reinterpreting these methods in Bayesian terms seemed to offer little of substance to the 
issue of improving methods in this area. At the other extreme, application of Bayesian methods to 
decisionmaking poses the very difficult problem of ascertaining the values of those affected by 
decisions, a necessary input. The workshop advisory committee concluded that health risk 
assessment, particularly dose–response assessment, can benefit from infusion of Bayesian logic and, 
under appropriate circumstances, the use of Bayesian statistical methods.  
Summaries of Faculty Presentations 
Following introductory remarks by James Wilson (RFF) and William (Bill) Farland (EPA), who set 
out EPA’s objectives, Tom Louis (RAND Corporation) described Bayesian logic and statistics and 
their use in informing conclusions. He explained that conclusions based on statistical analyses can 
depend on how questions are framed, illustrating his point with some examples drawn from 
toxicological and medical literature. He contrasted Bayesian and conventional statistical 
(“frequentist”) approaches, and the consequences for experimental design. From an appropriate 
Bayesian design, more information can often be obtained with a particular input of resources. He 
concluded that, in general, using Bayesian logic permits greater flexibility but demands more thought 
in the beginning stages.  
Kevin Brand (University of Ottawa) compared and contrasted several computational approaches 
used for approximating a posterior distribution. Most useful when closed-form (conjugate prior-
based) expressions for the posterior distribution are unavailable (the more general case), these 
approaches were classified into noniterative and iterative approaches. Noniterative approaches were 
further classified into direct (for example, Monte Carlo Integration) and indirect methods, including 
importance sampling, sampling importance resampling, and acceptance rejection sampling. He 
described the steps involved in each of these procedures and demonstrated them on two simple 
problems in regulatory toxicology. He then introduced a promising and publicly available Windows 
program called WinBUGs, which implements Bayesian inference using Gibbs sampling (an iterative 
approach). He then briefly demonstrated the software, highlighting the software’s use of “directed 
graphs” in structuring the logic of the analysis.  
Warner North (NorthWorks), a long-time practitioner of risk and decision analysis, described two 
applications to case studies: one involving public policy on weather modification, and the other 
involving microbial contamination on a National Aeronautics and Space Administration spacecraft. 
His examples illustrated the usefulness of Bayesian analysis for gaining insight into which 
uncertainties are most important and evaluating how uncertainties can be reduced by further research 
and experimentation.  
Donald Berry (University of Texas, M.D. Anderson Cancer Center) described some of his work in 
using Bayesian statistics to design and interpret drug trials. He repeated Louis’s statement that 
Bayesian study designs allow maximal use to be made of limited resources—in his case, patients in 
drug trials. Berry claimed that using Bayesian analysis allows the key parameters in drug design and 
testing to be obtained sooner and with less risk to patients.  Resources for the Future    Wilson 
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The first day closed with an exercise in estimating prior knowledge led by Alison Cullen (University 
of Washington).  
The workshop’s second day was devoted to illustrating uses of Bayesian analysis in risk analysis. 
Mitchell Small (Carnegie Mellon University) described some of his work done to estimate 
exposures. He showed how Bayesian methods can be used to refine a map of how differing treatment 
technologies for arsenic in water are distributed across the country. A workshop participant 
commented that this analysis makes an important contribution to risk management models for arsenic 
contamination. Igor Linkov (Menzie-Cura & Associates) described application of Bayesian 
techniques for model calibration. He presented a model that estimates the bioaccumulation of 
pollutants in different reaches of a stream. The model calibrated using experimental data collected in 
one reach provided understanding of other target areas. Bayesian calibration techniques can be used 
to incorporate limited amounts of uncertain data in modeling.  
Anthony (Tony) Cox (Cox Associates) gave a well-received lecture on use of Bayesian methods, 
focusing on his work on inferring causality from epidemiological study results. He introduced the use 
of a technique called “causal graphs” that both facilitates the analysis of and clarifies relationships 
among variables that feature complex interactions.  
Daniel (Dan) Byrd (CTRAPS) followed by describing use of a Bayesian analysis to infer the 
location of a threshold in cancer risk from arsenic exposure. The day closed with a panel discussion 
by Byrd, Cox, North, and Harvey Richmond (EPA) focussing on issues in the use of Bayesian 
approaches in dose–response analysis.  
The third day began with Annie Jarabek (U.S. EPA) describing how use of Bayesian analysis 
clarifies the presentation of regulatory risk analysis results and associated uncertainties and facilitates 
complex analyses, that is, drawing inferences from apparently conflicting data sets.  
The day concluded with a panel consisting of Jarabek, James Cogliano (EPA), Adam Finkel (U.S. 
Occupational Safety and Health Administration), Mark Youngren (Mitre Corporation), and Lauren 
Zeise (California EPA) and facilitated by Donald Barnes (EPA). This panel discussed barriers to the 
introduction of new methods and technologies and ways these barriers might be overcome. Their 
observations and suggestions are summarized below.  
Feedback from participants indicated that one of the sponsors’ goals was met: audience members 
reported that they gained an expanded understanding of Bayesian logic and statistics, their utility, and 
the diversity of present applications.  
Significant Findings 
Bayesian Approaches Can Improve Risk Analysis Practices 
Participants in the workshop agreed that wider use of Bayesian approaches can improve human health 
risk assessment practices. Areas judged to pose most significant opportunities include 
•  estimating exposure–response functions; 
•  inferring causality, especially when interpreting results of epidemiological studies; and  Resources for the Future    Wilson 
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•  performing complex exposure assessments.  
Conventional health risk assessment derives from the method developed some 50 years ago to 
evaluate the safety of chemicals used as food additives. Although this method was based on 
sophisticated biology and serves us very well in appropriate applications, its limitations burden its 
progeny. These are not sophisticated analytical tools. Practitioners in the field are increasingly 
coming to realize that many important decisions are not adequately informed by assessments done 
using these derived methods. The need for better analytical methods is particularly acute in the 
evaluation of dose–response functions. Current methods are not able to make use of a wealth of data 
that can be generated using tools of modern biochemistry and molecular genetics.  
One of the most pressing needs facing risk assessment practitioners is estimating responses that are 
small but not zero. What are we to make of exposures that exceed levels judged safe, but not by 
enough for toxicologists to conclude that the exposures are actually harmful? The proper measure for 
this would be the probability of injury or harm, given exposure. This metric requires identification of 
a true dose–response relationship and precise evaluation of associated parameters. Workshop 
participants agreed that Bayesian methods are particularly appropriate for this kind of task.  
Inferring causality from epidemiological study results presents possibly the most contentious process 
within the subdiscipline. Bayesian analytical methods permit much more precise and robust 
conclusions concerning causality than do conventional methods.  
Bayesian approaches have begun to be applied to assessments of exposure for both human health and 
environmental risks. Two very different applications of this kind were presented in the workshop. Use 
of Bayesian approaches brings to exposure assessment many of the same kinds of advantages 
expected for dose–response assessment: more effective use of diverse data, more robust conclusions, 
and a better understanding of uncertainties.  
Barriers to Acceptance of Bayesian Methods Exist and Can Be Overcome 
Workshop participants identified several barriers to acceptance of Bayesian approaches in dose–
response assessment and suggested several approaches to overcoming those barriers. They are 
summarized here. 
Existing Barriers to Acceptance 
•  Policymakers’ reluctance to depart from previous practices 
•  Simple inertia (on the part of analysts) 
•  Fear of how new methods will be viewed by the public (“How will it play in Peoria?”) 
•  Criticism stemming from the discovery of uncertainties in the old methods 
•  Uncertainties about whether new methods will be applicable in practice 
•  Uncertainty about what constitutes an “adverse effect” 
Suggestions for Overcoming These Barriers 
•  Develop champions for new methods among the affected technical community Resources for the Future    Wilson 
5 
•  Integrate new methods into ongoing business; apply them to solve serious problems 
•  Develop arguments that will support and promote the concept that change brings benefits 
and improves on existing practices 
•  Choose first uses carefully, and attempt to avoid disasters 
•  Work to achieve buy-in among affected groups; demand-pull marketing is vital 
•  Obtain peer review as development progresses 
All the barriers identified—save the last—commonly hinder innovations of the kind of interest here, 
adopting Bayesian methods for use in dose–response assessment. They occur in almost every 
organization whenever some process change is being advocated or considered. They follow from 
some common human traits, including fear of the unknown, fear of loss of power, and fear of 
criticism. Typically, organizational innovations are successful when they are strongly backed by 
someone (or a group) with high status in the organization, whether formal or informal. They can be 
people who lead by example, showing their fellows that using the new ways makes life easier or 
allows something to be done that previously was nearly impossible.4 The suggestions for overcoming 
the barriers reflect this experience.  
The last barrier identified, uncertainty about what constitutes an “adverse effect,” is both specific to 
our discipline and an issue with rather broad ramifications within the practice of regulatory risk 
assessment. Most regulations focus on preventing harm (although that thought may be expressed in 
any of several different ways). About three decades ago, the notion of “harm” became associated with 
a term of toxicologist’s art, “adverse effect.” Once upon a time, there existed a broad consensus on 
the kinds of responses in test animals observed to follow chemical treatment that should be 
considered “adverse”; it focused on death and serious illnesses such as cancer and skeletal deformities 
in test animals’ offspring. In recent years, however, advances in biochemistry, molecular biology, and 
genetics have provided toxicologists with tools that can identify small changes in treated animals. 
Some of these responses, such as the induction of detoxifying enzymes, are generally considered to be 
“adaptive”—that is, changes that will disappear without permanent harm to the animal were chemical 
treatment to be discontinued. But for many analysts, the meaning is ambiguous. This ambiguity poses 
something of a barrier to estimating exposure–response functions: which responses should be 
considered?  
Recommendations 
The workshop participants voiced several suggestions for promoting use of Bayesian analysis in 
dose–response assessment. 
                                                       
4 For two scholarly views of this process, see books by R.M. Kanter [The Change Masters: Innovation and 
Entrepreneurship in the American Corporation. New York: Simon and Schuster (1983)] and by C. Argyris and 
D.A. Schön [Theory in Practice: Increasing Professional Effectiveness. San Francisco CA: Jossey-Bass 
Publishers (1974)]. Resources for the Future    Wilson 
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1.  EPA, other regulatory agencies that use dose–response assessment as part of their 
processes, and the private sector all should take steps to foster the use of Bayesian 
approaches.  
2.  EPA and other agencies should work to persuade professional societies (for example, 
Society for Risk Analysis, Society of Toxicology) to seek out and recognize meritorious 
analyses that use Bayesian approaches.  
3.  EPA and private-sector organizations should consider sponsoring research into using 
Bayesian approaches, demonstrating analyses that use them, and using the results of this 
work to help educate peers in the risk analysis and toxicology professions. 
4.  EPA should request all staff and contractor scientists who develop mathematical models 
to use Bayesian techniques to calibrate models. This is the least controversial and most 
straightforward application of Bayesian logic. 
5.  EPA should consider ways to inform its staff, contractors, and the research community as 
to the utility of Bayesian analyses. In particular, EPA might consider the following 
suggestions: 
•  Invite proposals for research into components of a general method for conducting 
Bayesian-based exposure–response assessment. 
•  Identify the substances for which having good, relatively accurate exposure–response 
functions available might impact policy decisions. Such knowledge would provide 
EPA and other researchers with leads toward useful research. 
•  Give consideration to the value of internal training in the basics of Bayesian logic 
and statistics. 
6.  EPA should consider improving its research planning by making use of Bayesian 
techniques (including value-of-information analyses). Doing so would allow the agency 
to understand the relative importance of different topics and to help target research 
projects and programs toward those that will enable more accurate assessments of the 
consequences of environmental policies.  Resources for the Future    Wilson 
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Appendix I: Agenda 
 September  18   
8:30 A.M. Registration   
9:00 A.M.  WELCOME (and administrative)  James D. Wilson (RFF) 
9:15 A.M. INTRODUCTION:  Purpose and Importance of the Workshop   William Farland (EPA) 
9:45 A.M. LECTURE:  Theory of Bayesian Logic and Statistics—introduce 
concepts, illustrate range of uses, describe limitations  
Thomas Louis  
(RAND Corp.) 
10:30 A.M. Break   
10:45 A.M. DEMONSTRATION:  Using Readily-Available Software to 
Compute Posteriors, Given Appropriate Input 
Kevin Brand (U. 
Ottawa) 
11:45 A.M. Lunch   
1:00 P.M. LECTURE:  Applying Bayesian Logic in a Decision Context—
review theory, describe application to relevant decisions 
W. North (NorthWorks) 
1:45 P.M.  Discussion and questions   Panel 
2:00 P.M. LECTURE:  Use of Bayesian Approaches In Medical 
Research—Clinical Trials—illustrate use, need to identify 
appropriate priors 
Donald Berry (U. of 
Texas, M.D. Anderson 
Cancer Center) 
2:45 P.M. Discussion  and  questions   
3:00 P.M. Break   
3:15 P.M. EXERCISE:  Identifying Inputs  Alison Cullen (U. of 
Washington), leader 
5:15 P.M.  PLENARY: Discuss exercises, what was learned   Panel 
6:00 P.M.  Adjourn for the day   
    
 September  19   
8:45 A.M.  PLENARY: Plan for the day, questions   
9:00 A.M. LECTURE:  Using Disparate Data in Exposure Assessment  Mitchell  Small 
(Carnegie Mellon U.) 
9:45 A.M. Discussion  and  questions   
10:00 A.M. Break   
10:15 A.M. DEMONSTRATION:  Application to ecological risk—illustrate 
use, illustrate how to deal with errors in data  
Igor Linkov (Menzie-
Cura & Associates) 
11:30 A.M. Discussion  and  questions  Panel 
11:45 A.M. Lunch   
1:00 P.M. LECTURE:  Bayesian Risk Assessment: Combining Evidence 
from Multiple Sources 
L. Anthony Cox (Cox 
Associates)  
1:45 P.M. Discussion  and  questions   
2:00 P.M. DEMONSTRATION:  Constructing an Exposure–Response 
Function  
Daniel Byrd, (CTRAPS) 
2:45 P.M. Discussion  and  questions   
3:00 P.M. Break   
3:15 P.M. PANEL  DISCUSSION:  Issues in Estimating Dose–Response 
Functions  
Panelists Resources for the Future    Wilson 
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 PLENARY:  General Discussion   
5:00 P.M.  Adjourn for the day   
    
 September  20   
8:30 A.M. DEMONSTRATION:  Bayesian Applications in Routine 
Regulatory Risk Assessment 
Annie Jarabek (EPA) 
9:15 A.M. Discussion  and  questions   
9:30 A.M.  PLENARY: Review of exercises, questions, and discussion  J. Wilson and A. Jarabek 
10:15 A.M. Break   
10:30 A.M. PANEL  DISCUSSION:  Where Do We Go from Here? 
Applications and Research Needs 
Donald Barnes (EPA) 
and panelists  
12:00 noon  Adjourn (lunch provided)   Resources for the Future    Wilson 
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TORONTO, ON, CANADA; PHONE: (416) 592-7475; FAX: (416) 592-3449; E-MAIL: 
paul.hader@ontariopowergeneration.com 
HARPER, SUSAN, U.S. FDA, RR 2 BOX 928, HARPERS FERRY, WV 25425; PHONE:  
(301) 827-6462; FAX: (301) 594-2297; E-MAIL: sharper@cvm.fda.gov 
HAYWARD, STEPHEN, BANTING BLDG 2203B, TUNNEY’S PASTURE, OTTAWA, ON K1A 
0L2, CANADA; PHONE: (613) 954-6518; FAX: (613) 954-1574  
HENRY, SARA HALE, U.S. FDA, HFF-308, 200 C ST SW, WASHINGTON, DC 20204; PHONE: 
(202) 205-0191; FAX: (202) 260-0498; E-MAIL: shenry@cfsan.fda.gov 
HERTZBERG, RICHARD, U.S. EPA, 61 FORSYTH ST, ATLANTA, GA, 30303-3104; PHONE: 
(404) 562-8663; FAX: (404) 562-9964; E-MAIL: hertzberg.rick@epa.gov 
HETES, ROBERT, USEPA, MD-13, RES TRIANGLE PK, NC 27711; PHONE: (919) 541-1589; 
FAX: (919) 541-0840; E-MAIL: hetes.bob@epa.gov 
HOFFMAN, F. OWEN, SENES OAK RIDGE INC., 102 DONNER DR, OAK RIDGE, TN, 37830; 
PHONE: (423) 483-6111; FAX: (423) 481-0060; E-MAIL: senesor@senes.com 
HOFFMAN, SANDRA, RESOURCES FOR THE FUTURE, 1616 P ST NW, WASHINGTON, DC 
20036; PHONE: (202) 382-5022; FAX: (939) 3460; E-MAIL: hoffmann@rff.org 
HUMPHREYS, SUSIE, U.S. FDA, HFS 308, 200 C ST SW, WASHINGTON, DC 20204; PHONE:  
(202) 205-2670; FAX: (202) 260-0498; E-MAIL: shumphre@cfsan.fda.gov 
-J- 
JARABEK, ANNIE, NCEA (MD-52), U.S. EPA, RTP, NC 27711; PHONE: (919) 541-4847; FAX: 
(919) 541-1818; E-MAIL: jarabek.annie@epa.gov 
JENSEN, ELKE, U.S. FDA, HFS 246, 200 C ST SW, WASHINGTON, DC 20204; PHONE:  
(202) 478-3006; FAX: (202) 478-3030; E-MAIL: ejensen@cfsan.fda.gov 
JESSUP, AMBER, U.S. FDA/CFSAN, 200 C ST SW, HPS 726, WASHINGTON, DC 20204; 
PHONE: (202) 205-5270; FAX: (202) 260-0794; E-MAIL: amber.jessup@cfsan.fda.gov 
JINOT, JENNIFER, U.S. EPA, 1200 PENNSYLVANIA AVE NW, MC 8623-D, WASHINGTON, 
DC 20460; PHONE: (202) 564-3281; FAX: (202) 565-0079; E-MAIL: 
jinot.jennifer@epa.gov 
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KADRY, ABDEL-RAZAK, CTD/OPHS/FSIS/USDA, RM 6912, FRANKLIN COURT STE, 1400 
INDEPENDENCE AVE SW, WASHINGTON, DC 20250-3700; PHONE: (202) 690-6608; 
FAX: (202) 690-6565; E-MAIL: abdel-razak.kadry@usda.gov 
KHEIFETS, LEEKA, 3412 HILLVIEW AVE, PALO ALTO, CA 94303; PHONE: (650) 855-8976; 
FAX: (650) 855-1069; E-MAIL: kheifets@epri.com 
KIM, IN SUK, USDA, FRANKLIN COURT, 14TH NW, RM 6919, WASHINGTON, DC 20005; 
PHONE: (202) 501-7358; FAX: (202) 501-7639; E-MAIL: insuk.kim@usda.gov 
KLEMM, W. JEFFREY, SAIC, 1410 SPRINGHILL RD, STE 210, MCLEAN, VA 22102; PHONE: 
(703) 288-6849; FAX: (703) 356-8408; E-MAIL: w.jeffrey.klemm@saic.com 
-L- 
LEE, PATRICIA, WSRC, BUILDING 773-42A, AIKEN, SC, 29808; PHONE: (803) 725-3280; 
FAX: (803) 725-7673; E-MAIL: patricia.lee@srs.gov 
LEWIS, STEVEN, EXXON BIOMED SCIENCES, 1545 ROUTE 22 EAST, PO BOX 971, 
ANNANDALE, NJ, 08801-0971; PHONE: (908) 730-1036; FAX: (908) 730-1197; E-MAIL: 
sclewis@erenj.com 
LINKOV, IGOR, ARTHUR D. LITTLE, INC., 20 ACORN PARK, CAMBRIDGE, MA 02140; 
PHONE: (617) 566-8640; FAX: (617) 498-7019; E-MAIL: linkov.igor@adlittle.com 
LONGSTRETH, JANICE D., TIGRR, 9119 KIRKDALE RD, BETHESDA, MD 20817; PHONE: 
(301) 530-1527; FAX: (301) 530-8071; E-MAIL: tigerr@cpcug.org 
LOUIS, THOMAS, RAND CORPORATION, 1200 S HAYES ST, ARLINGTON VA 22202-5012; 
PHONE: (703) 413-1100; × 5206; FAX: (703) 413-8111; E-MAIL: tlouis@rand.org 
-M- 
MARGOSCHES, ELIZABETH, U.S. EPA, 1200 PENNSYLVANIA AVE SW, WASHINGTON, 
DC 20460; PHONE: (202) 260-1511; FAX: (202) 260-1279; E-MAIL: 
margosches.elizabeth@epa.gov 
McELVAINE, MICHAEL, USDA ORACBA, 1325 13TH ST NW, #32, WASHINGTON, DC 
20005; PHONE: (202) 720-8022; FAX: (202) 720-1815; E-MAIL: 
michael.mcelvaine@usda.gov 
MULLIKIN, JAMES, 5158 BLACKHAWK RD, APG, MD 21010; PHONE: (410) 436-2656; FAX: 
(410) 436-8261; E-MAIL: james.mullikin@apg.amedd.army.mil 
-N- 
NELSON, CHRISTOPHER, U.S. EPA, OFF OF RAD & INDOOR AIR, 1200 PENNSYLVANIA 
AVE NW, WASHINGTON, DC 20460; PHONE: (202) 564-9209; FAX: (202) 565-2778;  
E-MAIL: nelson.chris@epa.gov 
NELSON, NEAL, U.S. EPA, 1200 PENNSYLVANIA AVE NW, WASHINGTON, DC 20460; 
PHONE: (202) 564-9208; FAX: (202) 565-9629; E-MAIL: nelson.neal@epa.gov Resources for the Future    Wilson 
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NORTH, WARNER, NorthWorks, 1002 MISTY LN, BELMONT, CA 94002; PHONE:  
(650) 508-8858; FAX: (650) 591-2923; E-MAIL: northworks@mindspring.com 
-P- 
PAWEL, DAVID, U.S. EPA, 1200 PENNSYLVANIA AVE NW, WASHINGTON, DC 20460; 
PHONE: (202) 564-9202; FAX: (202) 565-2065; E-MAIL: pawel.david@epa.gov 
PETERSON JR., HAROLD T., 2720 WELLER RD, SILVER SPRING, MD 20906; PHONE:  
(202) 586-9640; FAX: (202) 586-3915; E-MAIL: harold.peterson@eh.doe.gov 
PHIBBS, PAT, BNA’S DAILY ENVIRONMENTAL REPORT, 1231 25TH ST NW, 
WASHINGTON, DC 20037; PHONE: (202) 452-4106; FAX: (202) 452-4150; E-MAIL: 
pphibbs@bna.com 
PHILLIPS, MARK, 4800 OAK GROVE DR, 301-472, PASADENA, CA 91109; PHONE:  
(818) 354-1181; FAX: (818) 393-4290; E-MAIL: j.m.phillips@jpl.nasa.gov 
POWELL, MARK, USDA/OCE/ORACBA, RM 5248 S AG BLDG, 1400 INDEPENDENCE AVE, 
SW, WASHINGTON, DC 20250; PHONE: (202) 720-9786; FAX: (202) 720-4240; E-
MAIL: mark.powell@usda.gov 
PURO, ED, U.S. FDA (HFS 726), 200 C ST, SW, WASHINGTON, DC 20204; PHONE:  
(202) 205-4279; FAX: (202) 260-0796; E-MAIL: edward.puro@cfsan.fda.gov 
PUTZRATH, RESHA, GEORGETOWN RISK GROUP, 3223 N ST NW, WASHINGTON, DC 
20007; PHONE: (202) 342-2110; FAX: (202) 337-8103; E-MAIL: 
rmputzrath@mindspring.com 
-R- 
RICHMOND, HARVEY, U.S. EPA, MD 15, RTP, NC 27711; PHONE: (919) 541-5271; FAX: (919) 
541-0237; E-MAIL: richmond.harvey@epa.gov 
RIMAWI, KARIM, NYS DEPT OF HEALTH, 547 RIVER ST, RM 530, TROY, NY 12180-2216; 
PHONE: (518) 402-7550; FAX: (518) 402-7554; E-MAIL: kxr01@health.state.ny.us 
RODAN, BRUCE, U.S. EPA, ORD/NCEA, 401 M ST SW (8601D), WASHINGTON, DC 20460; 
PHONE: (202) 564-3329; FAX: (202) 565-0066; E-MAIL: rodan.bruce@epa.gov 
ROUSE, TINA, U.S. FDA/CFSAN, 200 C ST SW, HFS 308, WASHINGTON, DC 20204; PHONE: 
(202) 230-5415; FAX: (202) 260-0498; E-MAIL: trouse@cfsan.fda.gov 
-S- 
SCHAEFFER, VAL, OSHA, 200 CONSTITUTION AVE NW, RM 3718, WASHINGTON, DC 
20210; PHONE: (202) 693-2279; FAX: (202) 693-1678; E-MAIL: val.schaeffer@osha.gov 
SCHLOSSER, PAUL, CIIT, PO BOX 12137, RTP, NC 27709; PHONE: (919) 558-1243; FAX: 
(919) 558-1300; E-MAIL: schlosser@ciit.org Resources for the Future    Wilson 
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SETTE, WILLIAM, U.S. EPA, 1200 PENNSYLVANIA AVE NW, 401 M ST SW, WASHINGTON, 
DC 20460; PHONE: (703) 305-6375; FAX: (703) 605-0645; E-MAIL: 
sette.william@epa.gov 
SMALL, MITCHELL, CIVIL & ENVIRONMENTAL ENGINEERING, CARNEGIE MELLON 
UNIVERSITY, PITTSBURGH, PA, 15213-3890 PHONE: (412) 268-8782; FAX:  
(412) 268-7813; E-MAIL: ms35@andrew.cmu.edu 
SMITH, MARK, 2203B BANTING, TUNNEY’S PASTURE, OTTAWA, ON K1A 0L2, CANADA; 
E-MAIL: mark_smith@hc-sc.gc.ca 
SPITZER, HUGH, ENVIRONMENTAL NETWORK, 6403 MARYWOOD RD, BETHESDA, MD 
20817; PHONE: (301) 530-6843; FAX: (301) 530-6891  
STORM, JAN, NY DEPT OF HEALTH/B OF TOX SUB, FLANIGAN SQUARE ROOM 300, 547 
RIVER ST, TROY, NY 12180; PHONE: (518) 402-7800; FAX: (518) 402-7819; E-MAIL: 
jstorm@kumc.edu 
SUDDUTH, DIANE, LINVATEC, 11311 CONCEPT BLVD, LARGO, FL 33773; PHONE:  
(727) 399-5248; FAX: (727) 399-5264; E-MAIL: dsudduth@linvatec.com 
SZWED, PAUL, U.S. COAST GUARD, 2100 SECOND ST, WASHINGTON, DC 20593; PHONE: 
(202) 267-0171; E-MAIL: pszwed@comdt.uscg.mil 
-T- 
TAO, SHIRLEY, U.S. FDA, HFS-308, 200 C ST, SW, WASHINGTON, DC 20204; PHONE:  
(202) 205-2972; FAX: (202) 260-0498; E-MAIL: stao@cfsan.fda.gov 
TRIPATHI, KAMALA, USDA, FSIS, OPPDE, ISDD, 202 ANNEX BLDG, WASHINGTON, DC 
20250; PHONE: (202) 205-0063; FAX: (202) 690-0824; E-MAIL: kamala.tripathi@usda.gov 
-V- 
VARDON, PETER, RFF, 1616 P ST, WASHINGTON, DC 20036; PHONE: (202) 205-5329;  
E-MAIL: pvardon@cfsan.fda.gov 
VICARI, ANDREA S., NC STATE UNIVERSITY, 8300 AUTUMN WINDS DR, RALEIGH, NC 
27615; PHONE: (919) 845-7170; FAX: (919) 513-6464; E-MAIL: andrea_vicari@ncsu.edu 
-W- 
WILSON, JAMES D, RESOURCES FOR THE FUTURE, 1616 P ST, WASHINGTON, DC 20036; 
PHONE: (202) 328-5099; FAX: (202) 939-3460; E-MAIL: wilson@rff.org 
WONG, DIANA, U.S. EPA, MC 4304, 1200 PENSYLVANIA AVE, WASHINGTON, DC 20460; 
PHONE: (202) 260-7838; FAX: (202) 260-1036; E-MAIL: wong.dianam@epa.gov 
WOODALL, GEORGE, API, 1220 L ST NW, WASHINGTON, DC 20005; PHONE: (202) 682-
8067; FAX: (202) 682-8031; E-MAIL: woodallg@api.org 
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YIM, MAN-SUNG, NORTH CAROLINA STATE UNIVERSITY, BOX 7909, RALEIGH, NC 
27695; PHONE: (919) 515-1466; FAX: (919) 515-5115; E-MAIL: yim@ncsu.edu 
YOUNGREN, MARK, MITRE CORPORATION, 1820 DOLLY MADISON BLVD, MS W625, 
MCLEAN, VA 22102-3481; E-MAIL: youngren@mitre.org 
-Z- 
ZEISE, LAUREN, CA/EPA/RCHAS, 16TH
 FLOOR, 1515 CLAY ST, OAKLAND, CA 94612; 
FAX: (510) 540-2695; E-MAIL: lzeise@oehha.ca.gov Resources for the Future    Wilson 
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Appendix IV: Some Electronic Sources of Information5 
http://bayes-an@xxx.lanl.gov—The bayesian repository is a project of the International Society for 
Bayesian Analysis. It is a fully automated e-print archive (starting from June 1, 1995) 
intended for papers that use or develop Bayesian methods of statistical inference. Appropriate 
topics include but are not limited to computational techniques, computer programs, control 
theory, decision analysis, empirical Bayes, entropy/maxent, estimation, 
forecasting/prediction, historical studies, information theory, invariance, model formulation, 
model selection, mathematical methods, nonparametrics and semiparametrics, prior 
distributions, robustness, sequential analysis, signal and image processing, testing, and 
theory/foundations. Specific applications of Bayesian methods to diverse fields such as 
medicine, law, physical sciences, economics, agriculture, marketing, and engineering are also 
appropriate. Internet access is available via this URL. To communicate with the archive via e-
mail, send messages to bayes-an@xxx.lanl.gov. Anonymous ftp access is available via 
xxx.lanl.gov 
http://www.bayesian.org/—The International Society for Bayesian Analysis (ISBA) was founded in 
1992 to promote the development and application of Bayesian statistical theory and methods 
useful in the solution of theoretical and applied problems in science, industry, and 
government. By sponsoring and organizing meetings and other activities, ISBA provides a 
focal point for those interested in Bayesian inference and its applications. The function of the 
website is to serve as a resource for members of ISBA and for the larger community of 
individuals who have an interest in Bayesian statistics. 
http://www.informs.org/society/da—DAWeb is the website of the Decision Analysis Society of 
INFORMS. The society promotes the development and use of logical methods for the 
improvement of decisionmaking in public and private enterprise. Such methods include 
models for decisionmaking under conditions of uncertainty or multiple objectives, techniques 
of risk analysis and risk assessment, experimental and descriptive studies of decisionmaking 
behavior, economic analysis of competitive and strategic decisions, techniques for facilitating 
decisionmaking by groups, and computer modeling software and expert systems for decision 
support. 
http://www.stat.ucla.edu/~jsanchez/sbssnews/history/history.html—The Section on Bayesian 
Statistical Science (SBSS) of the American Statistical Association (ASA) reflects a need for 
statisticians and people from other disciplines who have interests in the Bayesian paradigm to 
formalize their common interests within the statistical community represented by ASA. Some 
of the people interested in forming such a section had already clustered together over the 
years in small special interest groups relating to Bayesian statistics. It was their hope that the 
ASA SBSS would provide a common focus for these groups, as well for the wider scientific 
community. 
                                                       
5 The author is indebted to D.M. Byrd for providing this listing. Resources for the Future    Wilson 
18 
http://www.statslab.cam.ac.uk/~mcmc/—The Markov Chain Monte Carlo Preprint Service. 
http://dimacs.rutgers.edu/~dbwilson/exact.html/—The “perfectsimulation” home page: “Perfectly 
Random Sampling with Markov Chains.” 
http://www.mrc-bsu.cam.ac.uk/bugs/welcome.shtml—The BUGS project (Bayesian inference using 
Gibbs sampling) is a piece of computer software for the Bayesian analysis of complex 
statistical models using Markov chain Monte Carlo (MCMC) methods. It grew from a 
statistical research project at the MRC Biostatistics Unit but now is developed jointly with the 
Imperial College School of Medicine at St. Mary’s, London. 
http://bayes.stat.washington.edu/bayes_people.html—A list of websites of some Bayesian experts. 
http://omega.math.albany.edu:8008/JaynesBook.html—The contents of E.T. Jaynes’ book, 
Probability Theory: The Logic of Science.  Resources for the Future    Wilson 
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